• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Huntington's Disease 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Huntington's Disease trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Huntington's Disease research

New and better disease-modifying treatments for Huntington's disease (HD) are on the horizon, but effort remains in the quest to improve clinical research outcomes. Leverage our Signant SmartSignals end-to-end solutions and well as our in-house expertise in rare CNS disorders to address research challenges.

Why Signant Health

  • Improve Ratings Accuracy
  • Make It Easier to Participate
  • Simplify Assessments and Adherence for Participants
  • Ensure Endpoint Reliability
  • Increase Operational Efficiency
  • Improve Ratings Accuracy

    Improve Ratings Accuracy

    Endpoints in HD studies rely on UHDRS and other ClinROs, but inconsistencies in assessment scoring and administration can lead to difficulties interpreting the data collected. Signant's Rater Training program focuses on standardizing assessment technique and reducing inter- and intra-rater variability. We also create custom training tailored to the individual needs of each study for use across sites and programs.
     

  • Make It Easier to Participate

    Make It Easier to Participate

    Simplify the clinical trial experience for patients and sites alike by providing tools like eConsent and Telemedicine. These solutions help reduce unnecessary site visits, improve remote collaboration between sites and patients, and ensure protocol adherence.
     

  • Simplify Assessments and Adherence for Participants

    Partner with HD Experts

     From consulting on outcome measure selection and implementation to reducing burdens on sites and patients, Signant’s in-house experts will help you navigate common HD challenges throughout the study lifecycle. Talk through your protocol with our rare disease and CNS experts experienced in HD studies.
     

  • Ensure Endpoint Reliability

    Ensure Endpoint Reliability

    Guide investigative staff through proper ClinRO assessment technique using our enhanced clinician ratings platform. Automated scoring as well as built-in edit checks help reduce errors. When paired with Blinded Data Analytics, we can proactively monitor data in real-time, creating opportunities to mitigate risks before they impact your study data.
     

  • Increase Operational Efficiency

    Increase Operational Efficiency

    Conducting studies in multiple countries and across many sites introduces logistical challenges that can be the source of errors or delays. Study teams trust our RTSM system to not only launch studies faster but to handle complex cohorting, study supply forecasting, and data transfers with efficiency and accuracy.
     

Comprehensive Huntington's Disease experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Huntington's Disease trial resources
SOLUTION BROCHURE

Huntington's Disease Trial Solutions Overview


GET INSIGHTS
VIDEO

Huntington's Disease Trial Solutions


WATCH [2 MIN]
BLOG

5 Tips for Success in Rare Disease Studies


READ ARTICLE

eClinical solutions for Huntington's Disease trials

Ready to learn more?

Discover how Signant can support your current or upcoming Huntington's Disease trials. 

DOWNLOAD BROCHURE GET STARTED